Owens & Minor, Inc. (NYSE:OMI) Receives Average Rating of “Hold” from Brokerages

Owens & Minor, Inc. (NYSE:OMI – Get Rating) has been assigned an average recommendation of “Hold” from the seven analysts that are currently covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a sell recommendation and three have assigned a hold recommendation to the company. The average 1-year price target among brokers that have covered the stock in the last year is $19.20.

A number of research firms have issued reports on OMI. Robert W. Baird cut Owens & Minor from an “outperform” rating to a “neutral” rating and decreased their target price for the company from $62.00 to $22.00 in a research report on Wednesday, October 12th. TheStreet cut Owens & Minor from a “b-” rating to a “c” rating in a research report on Wednesday, November 2nd. StockNews.com began coverage on Owens & Minor in a research report on Wednesday, October 12th. They issued a “hold” rating on the stock. Bank of America cut Owens & Minor from a “buy” rating to an “underperform” rating and reduced their price target for the stock from $43.00 to $17.00 in a report on Wednesday, October 12th. Finally, Bank Of America (Bofa) cut Owens & Minor from a “buy” rating to an “underperform” rating and reduced their price target for the stock from $43.00 to $17.00 in a report on Wednesday, October 12th.

Owens & Minor Stock Up 1.5 %

OMI stock opened at $20.36 on Friday. The company has a market cap of $1.55 billion, a PE ratio of 12.73, a price-to-earnings-growth ratio of 1.98 and a beta of 0.64. The business has a 50-day simple moving average of $20.05 and a 200 day simple moving average of $24.64. Owens & Minor has a 52 week low of $14.10 and a 52 week high of $47.45. The company has a quick ratio of 0.58, a current ratio of 1.52 and a debt-to-equity ratio of 2.63.

Owens & Minor (NYSE:OMI – Get Rating) last released its earnings results on Wednesday, November 2nd. The company reported $0.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.39 by $0.02. Owens & Minor had a return on equity of 23.48% and a net margin of 1.24%. The firm had revenue of $2.50 billion for the quarter, compared to analysts’ expectations of $2.42 billion. Sell-side analysts anticipate that Owens & Minor will post 2.52 EPS for the current fiscal year.

Hedge Funds Weigh In On Owens & Minor

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. US Bancorp DE lifted its stake in shares of Owens & Minor by 34.6% in the second quarter. US Bancorp DE now owns 1,541 shares of the company’s stock worth $48,000 after acquiring an additional 396 shares during the period. Advisor Group Holdings Inc. lifted its stake in shares of Owens & Minor by 10.1% in the first quarter. Advisor Group Holdings Inc. now owns 4,858 shares of the company’s stock worth $214,000 after acquiring an additional 444 shares during the period. Delphia USA Inc. lifted its stake in shares of Owens & Minor by 8.2% in the first quarter. Delphia USA Inc. now owns 6,163 shares of the company’s stock worth $271,000 after acquiring an additional 469 shares during the period. Baird Financial Group Inc. lifted its stake in shares of Owens & Minor by 3.5% in the first quarter. Baird Financial Group Inc. now owns 14,784 shares of the company’s stock worth $650,000 after acquiring an additional 503 shares during the period. Finally, GPS Wealth Strategies Group LLC lifted its stake in shares of Owens & Minor by 62.2% in the second quarter. GPS Wealth Strategies Group LLC now owns 1,434 shares of the company’s stock worth $45,000 after acquiring an additional 550 shares during the period.

Owens & Minor Company Profile

(Get Rating)

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers.